FindMyKOL
Clinical trialNCT05907018CompletedObservational

Autonomic Monitoring in Neurocardiogenic Syncope

NCT05907018 is an observational study sponsored by Children's Hospital Medical Center, Cincinnati. As of 18 Nov 2026, it is completed. It studies Chest Pain, Dyspnea and 1 more condition. The registry lists an enrollment of 40 participants at 1 site in 1 country. The registry lists a start date of 12 May 2023 and a primary completion date of 23 Oct 2024.

SponsorChildren's Hospital Medical Center, CincinnatiEnrollment40Chest PainDyspneaSyncope
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05907018
FieldValue
Registry IDNCT05907018
StatusCompleted
Study typeObservational study
Lead sponsorChildren's Hospital Medical Center, Cincinnati
Enrollment40
Registered sites1
Countries1
ConditionsChest Pain, Dyspnea and Syncope
Start12 May 2023
Primary completion23 Oct 2024
Study completion23 Oct 2024
Last update posted29 Jan 2025

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a prospective observational pilot study of suitability of autonomic monitoring via the VU-AMS device for prediction of neurocardiogenic syncope (NCS) in children referred to cardiopulmonary exercise testing (CPET) for a diagnosis of syncope. The study population is children referred for CPET to evaluate for neurocardiogenic syncope. The purpose is to describe autonomic function during rest and exercise and determine the positive predictive value of autonomic function measurements against the gold standard for diagnosis of neurocardiogenic syncope, the CPET. Children presenting for CPET with chest pain or who are status post orthotopic heart transplantation will serve as positive and negative controls respectively.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Pornswan Ngamprasertwong, MD

    Children's Hospital Medical Center, Cincinnati

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ohio, United States1 site
  • Cincinnati Children's Hospital Medical Center

    Cincinnati

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT05907018

Each answer restates registry values shown on this page.

What is NCT05907018?

NCT05907018 is an observational study sponsored by Children's Hospital Medical Center, Cincinnati. It studies Chest Pain, Dyspnea and 1 more condition.

Who leads NCT05907018?

The registry names Pornswan Ngamprasertwong, MD (principal investigator, Children's Hospital Medical Center, Cincinnati) as the overall official.

Where does NCT05907018 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT05907018 end?

The registry lists a primary completion date of 23 Oct 2024 and a study completion date of 23 Oct 2024. The sponsor last updated the record on 29 Jan 2025.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.